Page last updated: 2024-08-18

pyrazolanthrone and Muscle Weakness

pyrazolanthrone has been researched along with Muscle Weakness in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Callahan, LA; Ji, X; Supinski, GS	1

Other Studies

1 other study(ies) available for pyrazolanthrone and Muscle Weakness

Article	Year
The JNK MAP kinase pathway contributes to the development of endotoxin-induced diaphragm caspase activation. American journal of physiology. Regulatory, integrative and comparative physiology, 2009, Volume: 297, Issue:3 Topics: Animals; Anthracenes; Caspase 8; Cell Line; Cytokines; Diaphragm; Disease Models, Animal; Enzyme Activation; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle Contraction; Muscle Fibers, Skeletal; Muscle Strength; Muscle Weakness; Phosphorylation; Protein Kinase Inhibitors; Sepsis; Time Factors; Transfection	2009

Article

Year

The JNK MAP kinase pathway contributes to the development of endotoxin-induced diaphragm caspase activation.

American journal of physiology. Regulatory, integrative and comparative physiology, 2009, Volume: 297, Issue:3

Topics: Animals; Anthracenes; Caspase 8; Cell Line; Cytokines; Diaphragm; Disease Models, Animal; Enzyme Activation; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle Contraction; Muscle Fibers, Skeletal; Muscle Strength; Muscle Weakness; Phosphorylation; Protein Kinase Inhibitors; Sepsis; Time Factors; Transfection

2009